Cargando…

Antibody titers and protection against a SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Dimeglio, Chloé, Herin, Fabrice, Martin-Blondel, Guillaume, Miedougé, Marcel, Izopet, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452591/ https://www.ncbi.nlm.nih.gov/pubmed/34560135 http://dx.doi.org/10.1016/j.jinf.2021.09.013

Ejemplares similares

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Quantifying the impact of public health protection measures on the spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Chapuy-Regaud, Sabine, et al.
Publicado: (2021)

Estimating the impact of public health strategies on the spread of SARS‐CoV‐2: Epidemiological modelling for Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Children are protected against SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2020)

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
por: Abravanel, Florence, et al.
Publicado: (2020)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
por: Bi, Xiuqiong, et al.
Publicado: (2022)

Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan
por: Kadowaki, Tomoka, et al.
Publicado: (2023)

Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations
por: Franchini, M., et al.
Publicado: (2022)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF
por: Andriuta, Daniela, et al.
Publicado: (2020)

Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
por: El Haggan, Wael, et al.
Publicado: (2022)

Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants
por: Migueres, M., et al.
Publicado: (2021)

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
por: Lazor-Blanchet, C., et al.
Publicado: (2022)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

The role of masks and respirator protection against SARS-CoV-2
por: Wang, Qiang, et al.
Publicado: (2020)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers
por: Migueres, Marion, et al.
Publicado: (2020)

Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2
por: Kayukawa, Satoshi, et al.
Publicado: (2021)

Is a COPD patient protected against SARS-CoV-2 virus?
por: Daubin, C., et al.
Publicado: (2021)

Structure-based development of human antibody cocktails against SARS-CoV-2
por: Wang, Nan, et al.
Publicado: (2020)

Protective Effect of Vaccine Doses and Antibody Titers Against SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Chen, Chien-Chia, et al.
Publicado: (2023)

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
por: Hanrath, Aidan T., et al.
Publicado: (2020)

Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
por: Arteaga-Müller, Giovanna Yazmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7taui3g0lp2u37pvi58uj3vs93